Establishing Reliability Criteria for Liver ElastPQ Shear Wave Elastography (ElastPQ-SWE): Comparison Between 10, 5 and 3 Measurements

Abstract

Purpose ElastPQ is a new elastography technique for non-invasive liver fibrosis staging. However, it does not have validated reliability criteria. We tested the reliability of a different number of measurements in patients with chronic liver disease and explored whether the application of quality criteria improves the diagnostic performance.

Materials and Methods All patients underwent liver stiffness assessment (LSM) with ElastPQ and Fibroscan (F-TE). The mean, median, standard deviation (SD) and interquartile range (IQR) of 10, 5 and 3 measurements were retrospectively collected for each patient and compared to each other. Liver histology was available in a subset of patients.

Results Overall, 400 patients met the inclusion criteria. Non-alcoholic fatty liver disease (NAFLD) was the most represented etiology (75 %), followed by primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH). The correlation of medians was significantly better between 10 and 5 measurements than between 10 and 3. The difference of medians was significant only in the comparison between 10 and 3 measurements. The correlation between ElastPQ and F-TE was equally good for 10 and 5 measurements and significantly improved after an IQR/median ≤ 30 % was applied. The diagnostic performance of ElastPQ was better with the median value of 10 and 5 measurements and improved if LSM values were obtained with IQR/M ≤ 30 %.

Conclusion The median value of 5 valid LSMs suffices for the reliable estimation of liver stiffness using ElastPQ. The quality criterion of IQR/M ≤ 30 % should also be followed when using this technique.

Zusammenfassung

Ziel ElastPQ ist ein neues elastografisches Verfahren für das nichtinvasive Staging der Leberfibrose, hat aber keine validierten Reliabilitätskriterien. Wir haben die Verlässlichkeit der verschiedenen Messungen bei Patienten mit chronischer Lebererkrankung getestet und untersucht, ob die Anwendung von Qualitätskriterien die diagnostische Leistung verbessert.

Material und Methoden Bei allen Patienten wurde eine Lebersteifigkeitsuntersuchung (LSM) mit ElastPQ und Fibroscan (F-TE) durchgeführt. Mittelwert, Median, Standardabweichung (SD) und Interquartilsabstand (IQR) von 10, 5 und 3 Messungen wurden retrospektiv für jeden Patienten erhoben und miteinander verglichen. Bei einer Untergruppe der Patienten war eine Leberhistologie verfügbar.

Ergebnisse Insgesamt erfüllten 400 Patienten die Einschlusskriterien. Die nichtalkoholische Fettleberkrankheit (NAFLD) war die am häufigsten vertretene Ätiologie (75 %), gefolgt von primärer sklerosierender Cholangitis (PSC), primärer biliärer Cholangitis (PBC) und Autoimmunhepatitis (AIH). Die Korrelation der Mediane war signifikant besser zwischen 10 und 5 Messungen als zwischen 10 und 3. Eine Differenz der Mediane war nur signifikant beim Vergleich von 10 und 3 Messungen. Die Korrelation zwischen ElastPQ und F-TE war für 10 und 5 Messungen gleichermaßen gut und verbesserte sich signifikant, wenn IQR/median ≤ 30 % angewendet wurde. Die diagnostische Leistung von ElastPQ war besser mit dem Medianwert von 10 und 5 Messungen und verbesserte sich, wenn LSM-Werte mit IQR/M ≤ 30 % erreicht wurden.

Schlussfolgerung Der Medianwert von 5 gültigen LSMs ist ausreichend für die zuverlässige Abschätzung der Lebersteifigkeit mittels ElastPQ. Auch bei dieser Methode sollte das Qualitätskriterium IQR/M ≤ 30 % eingehalten werden.

Key words

transient elastography - liver stiffness - non-alcoholic fatty liver disease - autoimmune liver disease - point shear wave elastography

Publikationsverlauf

Eingereicht: 11. Dezember 2018

Angenommen: 15. August 2019

Artikel online veröffentlicht:
08. Oktober 2019

• References

• 1 The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20
• 2 Boozari B, Potthoff A, Mederacke I. et al. Evaluation of sound speed for detection of liver fibrosis: prospective comparison with transient dynamic elastography and histology. J Ultrasound Med 2010; 29: 1581-1588
• 3 Tsochatzis E, Bruno S, Isgro G. et al. Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis. J Hepatol 2014; 60: 948-954
• 4 Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457
• 5 Regev A, Berho M, Jeffers LJ. et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618
• 6 Crossan C, Tsochatzis EA, Longworth L. et al. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess 2015; 19: 1-409
• 7 Lurie Y, Webb M, Cytter-Kuint R. et al. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol 2015; 21: 11567-11583
• 8 Tsochatzis EA, Gurusamy KS, Ntaoula S. et al. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-659
• 9 European Association for Study of L, Asociacion Latinoamericana para el Estudio del H. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015; 63: 237-264
• 10 Cassinotto C, Boursier J, de Ledinghen V. et al. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 2016; 63: 1817-1827
• 11 Ferraioli G, Tinelli C, Lissandrin R. et al. Point shear wave elastography method for assessing liver stiffness. World J Gastroenterol 2014; 20: 4787-4796
• 12 Ferraioli G, Filice C, Castera L. et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. Ultrasound Med Biol 2015; 41: 1161-1179
• 13 Dietrich CF, Bamber J, Berzigotti A. et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall in Med 2017; 38: e48
• 14 Kleiner DE, Brunt EM, Van Natta M. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321
• 15 Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-268
• 16 Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160
• 17 Thiele M, Madsen BS, Procopet B. et al. Reliability Criteria for Liver Stiffness Measurements with Real-Time 2D Shear Wave Elastography in Different Clinical Scenarios of Chronic Liver Disease. Ultraschall in Med 2017; 38: 648-654
• 18 Ferraioli G, Tinelli C, Dal Bello B. et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology 2012; 56: 2125-2133
• 19 Mulabecirovic A, Mjelle AB, Gilja OH. et al. Liver elasticity in healthy individuals by two novel shear-wave elastography systems-Comparison by age, gender, BMI and number of measurements. PloS one 2018; 13: e0203486
• 20 Karlas T, Pfrepper C, Wiegand J. et al. Acoustic radiation force impulse imaging (ARFI) for non-invasive detection of liver fibrosis: examination standards and evaluation of interlobe differences in healthy subjects and chronic liver disease. Scandinavian journal of gastroenterology 2011; 46: 1458-1467
• 21 Barr RG, Ferraioli G, Palmeri ML. et al. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology 2015; 276: 845-861
• 22 Ferraioli G, Maiocchi L, Lissandrin R. et al. Accuracy of the ElastPQ Technique for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C: a “Real Life” Single Center Study. J Gastrointestin Liver Dis 2016; 25: 331-335
• 23 Bota S, Sporea I, Sirli R. et al. Factors which influence the accuracy of acoustic radiation force impulse (ARFI) elastography for the diagnosis of liver fibrosis in patients with chronic hepatitis C. Ultrasound Med Biol 2013; 39: 407-412
• 24 Ferraioli G, De Silvestri A, Reiberger T. et al. Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment-A multicenter retrospective study. Dig Liver Dis 2018; 50: 1056-1061
• 25 Zakeri N, Tsochatzis EA. Steatosis affects the sensitivity but not the specificity of non-invasive fibrosis tests in non-alcoholic fatty liver disease – implications for screening strategies. Liver Int 2018; 38: 224-226
• 26 Cai YJ, Dong JJ, Wang XD. et al. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B. J Viral Hepat 2017; 24: 1005-1015
• 27 Boursier J, de Ledinghen V, Sturm N. et al. Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C. J Gastroenterol 2014; 49: 527-537
• 28 Macaluso FS, Maida M, Camma C. et al. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. J Hepatol 2014; 61: 523-529
• 29 Shi KQ, Tang JZ, Zhu XL. et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy. J Gastroenterol Hepatol 2014; 29: 1149-1158
• 30 Petta S, Wong VW, Camma C. et al. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. Hepatology 2017; 65: 1145-1155
• 31 Petta S, Di Marco V, Camma C. et al. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 2011; 33: 1350-1360